Prof. Dr. Ahmet Özdoğan
ENT — General

Agger Nasi Cells

Agger nasi cells are the most anterior ethmoid air cells located anterosuperior to the middle turbinate attachment, present on CT in 89–98% of the population; prominent cells narrow the frontal recess and predispose to frontal sinusitis.

Agger Nasi Cells is frequently researched by patients in general ENT, yet the search term alone is not enough to settle personal care. Agger nasi cells are the most anterior ethmoid air cells located anterosuperior to the middle turbinate attachment, present on CT in 89–98% of the population; prominent cells narrow the frontal recess and predispose to frontal sinusitis. Age, comorbidities, this entry side pattern, duration and previous report language change the clinical reading. the clinical point assessment brings nasal-sinus symptoms, the dictionary entry throat-tonsil context, this topic upper-airway impact and this term sleep links into one ENT frame. This entry uses a function-first way of assessing the finding and points to the questions worth preparing. For this entry, the existing summary aims to connect the reported complaint with examination findings: Pneumatised from the lacrimal bone or nasolacrimal duct area at the axilla of the middle turbinate, these cells when prominent (>10 mm AP diameter) form the posterior and inferior wall of the frontal recess, obstructing frontal sinus drainage. The topic is therefore read with clinical context, not as a one-line definition.

During a the clinical point consultation, the patient's description is compared with the examination finding. The this topic onset date, progression pattern, side difference, quality-of-life effect and prior treatment response are recorded. this term review may combine ENT examination, the finding endoscopic assessment, this entry oral cavity-oropharynx inspection and the clinical point audiological testing when useful. the dictionary entry decisions record fever, this topic pain-bleeding pattern, this term hearing or nasal blockage, the finding sleep impact and this entry infection recurrence separately. In this term, the clinical aim is to prove the finding that explains the complaint and separate similar-looking conditions: Identified on CT sagittal plane as a small air cell anterior to the middle turbinate attachment. Tests are requested when they help make that distinction. Diagnosis therefore rests on the whole clinical picture rather than one report sentence.

the finding care translates diagnosis into a practical pathway. Safety boundaries, functional loss, recovery time, possible complications and review needs are discussed in the same visit. this entry planning discusses medical treatment, the clinical point allergy control, the dictionary entry endoscopic procedures, this topic adenoid-tonsil strategy or this term airway surgery by indication. Management of the finding is individualized according to symptom duration, examination findings, functional impact, patient expectations, prior treatment response and imaging or laboratory results when needed. Balanced planning for this topic reduces avoidable delay and unnecessary intervention.

Review of this entry compares the baseline finding with the current the clinical point complaint using the same scale. the finding follow-up compares pain, this entry nasal openness, the clinical point sleep quality, the dictionary entry hearing impact and this topic infection recurrence over time. Safe communication about this term helps patients notice risky symptoms early without increasing anxiety and supports adherence to follow-up advice. If the finding develops this entry follow-up with high fever, increasing pain, worsening blockage or recurrent infection, review is brought forward.

Before the the clinical point visit, the patient can arrange onset date, side pattern, previous tests and medication history in a short sequence; consultation time can then focus on personal risk and care choices.

Diagnosis

CT sagittal section review identifies agger nasi cells and Kuhn frontal cell type (1–4). Large agger nasi plus Kuhn Type 3–4 = most challenging frontal recess anatomy. Proximity to the nasolacrimal duct should be assessed for lacrimal sac injury risk. Three-dimensional CT reconstruction enables surgical simulation; neuronavigation is becoming standard for complex anatomy.

Treatment

Endoscopic agger nasi cell resection with a 30° or 70° angled scope during Draf I (frontal recess only) or Draf IIA (partial frontal sinus floor removal) is performed. The medial wall of the lacrimal sac must be preserved. Frontal recess mucosal lining should be preserved to reduce stenosis risk. Draf IIB/III (modified Lothrop) can be planned for severe stenosis or failed Draf IIA.

Outcomes and Follow-up

Agger nasi removal successfully opens the frontal recess in >90% of cases. Revision frontal sinusotomy is needed in 10–15%, usually for stenosis. Draf IIB/III provides higher long-term patency rates but with increased technical demands. Post-operative endoscopy should be planned at 3 and 6 months; early treatment of stenotic ostia with balloon dilation prevents recurrence.

When to Seek Care

Recurrent frontal sinusitis despite maxillary/ethmoid FESS, persistent frontal headache, or a frontal sinus mucocoele expanding into the orbit warrants ENT specialist referral. When Kuhn Type 3–4 cells are identified on frontal recess CT, assessment by an experienced endoscopic sinus surgeon is recommended.

Frequently asked questions

What is Agger Nasi Cells?
Agger nasi cells are the most anterior ethmoid air cells located anterosuperior to the middle turbinate attachment, present on CT in 89–98% of the population; prominent cells narrow the frontal recess and predispose to frontal sinusitis. Agger Nasi Cells is frequently researched by patients in general ENT, yet the search term alone is not enough to settle personal care.
When is Agger Nasi Cells clinically important?
During a the clinical point consultation, the patient's description is compared with the examination finding. It is assessed together with examination, endoscopy or imaging in nasal, throat, sinus and upper-airway complaints.
When is ENT assessment relevant for Agger Nasi Cells?
ENT assessment becomes relevant if symptoms last more than a few weeks, become one-sided or progressive, or are accompanied by breathing, swallowing, voice, hearing or neck-mass findings.
What information helps assessment of Agger Nasi Cells?
It is useful to note when symptoms started, which side is affected, previous operations or treatments, current medication, imaging and test reports, and the effect on daily life. It is assessed together with examination, endoscopy or imaging in nasal, throat, sinus and upper-airway complaints.

Learn more about this procedure

Detailed guide from Prof. Dr. Özdoğan's clinic

View Guide →

References

This glossary entry is for informational purposes only and does not constitute medical advice. Consult a qualified specialist for diagnosis and treatment.

Back to Medical Dictionary
Message on WhatsAppCall